Did you survive the Visa apocalypse? What on forex market hours clocks has been going on in Italy and what does it mean for you? Trump’s tariffs explained: What are they, how has the world reacted and what are the implications for Britain and global trade? Some ten years ago Skyepharma received an unsolicited bid approach from an unknown concern which eventually came to nothing.
That was when the launch of flutiform, it’s potentially best-in-class combination asthma treatment, was years away. Yesterday, respiratory drug specialist Vectura, 5. Skyepharma touched 417p before closing 19. 25p on news of the agreed share-exchange terms. Skyepharma shareholders can elect to receive cash instead of some or all of the new Vectura shares to which they would otherwise be entitled under the merger. On the same day that it revealed it was to be swallowed by Vectura, Skyepharma reported excellent results. Strategically, the deal has strong rationale, with complimentary respiratory technologies, would provide a true one-stop shop for respiratory development, a strong combined pipeline, a more diversified revenue composition and stronger balance sheet.
London Stock Exchange, 36p lower at 2870p, and 54. 4 per cent equity owner Deutsche Boerse. It may create the largest financial exchange business in the world, but dealers were miffed to hear that in future the LSE, a great City of London institution, would be reporting its figures in euros. It all provided an interesting forerunner to George Osborne’s eighth annual Budget. Trading a couple of points up when the Chancellor stood up just after 12.